XERS stock forecast
Our latest prediction for Xeris Pharmaceuticals, Inc.'s stock price was made on the June 25, 2018 when the stock price was at 19.10$.
In the short term (2weeks), XERS's stock price should outperform the market by 4.79%. During that period the price should oscillate between -2.34% and +8.12%.
In the medium term (3months), XERS's stock price should outperform the market by 8.26%. During that period the price should oscillate between -5.37% and +21.39%.Get email alerts
About Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc.is a pharmaceutical company, which develops and commercializes ready-to-use, liquid-stable injectables. It offers XeriSol™ and XeriJect™ formulation technologies. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Austin, TX.
At the moment the company generates 2M USD in revenues.
On its last earning announcement, the company reported a loss of -4.21$ per share.
The book value per share is 5.25$
Three months stock forecastJune 25, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|